Aussie Variant Classification Effort Aims to Reduce Uncertainty in Hereditary Blood Cancer Diagnosis
The researchers hope to determine whether tens of thousands of variants in RUNX1 and GATA2 increase predisposition to blood cancers.
Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.
Diffuse Large B Cell Lymphoma Tumor, Microenvironment Features Explored With Single-Cell Atlas
Using single-cell RNA sequencing on more than 94,300 cells from 17 tumors, researchers identified expression clusters, tumor-microenvironment interactions, and more.
Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment
The test will identify patients expressing a genomic biomarker who are likely to respond to Denovo's investigational DB102 treatment for diffuse large B-cell lymphoma.
BostonGene Helping MassGeneral Improve Understanding of Follicular Lymphoma Progression, Treatment
The company will analyze tumor genetics and microenvironments to advance research into why some follicular lymphomas become aggressive and treatment response.